These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27216438)

  • 1. NAT2 polymorphisms and risk for Parkinson's disease: a systematic review and meta-analysis.
    Jiménez-Jiménez FJ; Alonso-Navarro H; García-Martín E; Agúndez JA
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):937-46. PubMed ID: 27216438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability and validity of polymorphism association studies in Parkinson's disease.
    Tan EK; Khajavi M; Thornby JI; Nagamitsu S; Jankovic J; Ashizawa T
    Neurology; 2000 Aug; 55(4):533-8. PubMed ID: 10953187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetyltransferase 2 (NAT2) gene polymorphisms in Parkinson's disease.
    Borlak J; Reamon-Buettner SM
    BMC Med Genet; 2006 Mar; 7():30. PubMed ID: 16571112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of slow acetylator genotype of N-acetyltransferase 2 with Parkinson's disease in south Indian population.
    Pandi S; Chinniah R; Sevak V; Ravi PM; Vijayan M; Vellaiappan NA; Karuppiah B
    Neurosci Lett; 2020 Sep; 735():135260. PubMed ID: 32682841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between Glutathione S-transferase M1/Glutathione S-transferase T1 polymorphisms and Parkinson's disease: a meta-analysis.
    Wang T; Wang B
    J Neurol Sci; 2014 Mar; 338(1-2):65-70. PubMed ID: 24382428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
    Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
    Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-metabolising enzyme polymorphisms and predisposition to anti-tuberculosis drug-induced liver injury: a meta-analysis.
    Sun F; Chen Y; Xiang Y; Zhan S
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):994-1002. PubMed ID: 18713495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of genetic polymorphisms of
    Yang S; Hwang SJ; Park JY; Chung EK; Lee JI
    BMJ Open; 2019 Aug; 9(8):e027940. PubMed ID: 31375612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of polymorphism in cytochrome P450 2D6 and N-acetyltransferase-2 with Parkinson's disease.
    Singh M; Khanna VK; Shukla R; Parmar D
    Dis Markers; 2010; 28(2):87-93. PubMed ID: 20364044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifying Effect of Smoking on GSTM1 and NAT2 in Relation to the Risk of Bladder Cancer in Mongolian Population: A Case-Control Study.
    Avirmed S; Khuanbai Y; Sanjaajamts A; Selenge B; Dagvadorj BU; Ohashi M
    Asian Pac J Cancer Prev; 2021 Aug; 22(8):2479-2485. PubMed ID: 34452561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.
    Firozi PF; Bondy ML; Sahin AA; Chang P; Lukmanji F; Singletary ES; Hassan MM; Li D
    Carcinogenesis; 2002 Feb; 23(2):301-6. PubMed ID: 11872636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease.
    van der Walt JM; Martin ER; Scott WK; Zhang F; Nance MA; Watts RL; Hubble JP; Haines JL; Koller WC; Lyons K; Pahwa R; Stern MB; Colcher A; Hiner BC; Jankovic J; Ondo WG; Allen FH; Goetz CG; Small GW; Mastaglia F; Roses AD; Stajich JM; Booze MW; Fujiwara K; Gibson RA; Middleton LT; Scott BL; Pericak-Vance MA; Vance JM
    Neurology; 2003 Apr; 60(7):1189-91. PubMed ID: 12682333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility.
    Hengstler JG; Arand M; Herrero ME; Oesch F
    Recent Results Cancer Res; 1998; 154():47-85. PubMed ID: 10026993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women.
    McGrath M; Michaud D; De Vivo I
    BMC Cancer; 2006 Oct; 6():239. PubMed ID: 17026750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
    Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I
    Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1,GSTT1, NAT1 and NAT2.
    Godschalk RW; Dallinga JW; Wikman H; Risch A; Kleinjans JC; Bartsch H; Van Schooten FJ
    Pharmacogenetics; 2001 Jul; 11(5):389-98. PubMed ID: 11470992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders.
    Hirvonen A; Saarikoski ST; Linnainmaa K; Koskinen K; Husgafvel-Pursiainen K; Mattson K; Vainio H
    J Natl Cancer Inst; 1996 Dec; 88(24):1853-6. PubMed ID: 8961976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of NAT2 gene polymorphism in aetiology of the most frequent neurodegenerative diseases with dementia.
    Gołab-Janowska M; Honczarenko K; Gawrońska-Szklarz B; Potemkowski A
    Neurol Neurochir Pol; 2007; 41(5):388-94. PubMed ID: 18033638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case-control study of debrisoquine 4-hydroxylase, N-acetyltransferase 2, and apolipoprotein E gene polymorphisms in Parkinson's disease.
    Maraganore DM; Farrer MJ; Hardy JA; McDonnell SK; Schaid DJ; Rocca WA
    Mov Disord; 2000 Jul; 15(4):714-9. PubMed ID: 10928584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.